• Click and Discover Platform set to buck trends in Drug Development
    Professor John Overington

News & Views

Click and Discover Platform set to buck trends in Drug Development

Aug 31 2021

Bioinformatics has seen the emergence of the first no-code, pay as you go drug discovery platform that simplifies access to AI models for SME’s at the click of a button. Developed by Chief.AI in partnership with the Medicines Discovery Catapult (MDC), the cloud-based system provides access to information, skills and resources along with production infrastructure and analytics for models without the need for substantial and expensive internal IT capabilities.
Supported by an Innovate UK grant, the project is based on the development of models by MDC, with Chief.AI providing the orchestration engine.
The ability to utilise AI in this way could provide huge advantages in terms of costs and timing as well as making efficient use of resources. For example, it could be used to analyse and predict the behaviour of molecules in the human body much earlier than traditional methods, which financially could save billions in research and development.
“As an orchestrator of AI, we are delighted to be able to make access to AI easier and more effective for healthcare providers around the world. Artificial intelligence will prove to be a great force multiplier for data intensive applications such as drug discovery and diagnostics and with the help of the Medicines Discovery Catapult, Chief.AI is strategically poised to enable businesses around the world to connect to AI and reap these efficiencies seamlessly,” said Chief.AI founder Waqar Ali.

Professor John P. Overington, Chief Informatics Officer, Medicines Discovery Catapult, added: “This is a very exciting time for drug discovery. The development and utilisation of AI has been something that the industry has needed to propel that next step forward, and with Chief.AI it is now possible. AI is going to be something that will permeate across all aspects of society and business in the years to come and it is wonderful that we are able to offer this platform to UK SMEs, providing them with information and expertise which otherwise would have been inaccessible.”

More information online


Digital Edition

International Labmate 49.6 - Sept 2024

September 2024

Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...

View all digital editions

Events

Lab Innovations 2024

Oct 30 2024 Birmingham, UK

SPIE Photonex

Oct 30 2024 Manchester, UK

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

View all events